Total Visits

Views
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 109

Total Visits Per Month

July 2020August 2020September 2020October 2020November 2020December 2020January 2021
Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors? 2 2 1 7 0 14 0

Top country views

Views
United States 61
China 31
Qatar 7
Germany 3
United Kingdom 1
Netherlands 1

Top cities views

Views
Ashburn 23
Zhengzhou 14
Fairfield 9
Ann Arbor 8
Shanghai 8
Jinan 5
Shenzhen 4
Woodbridge 3
Cambridge 2
Encino 2